Eribulin Mesylate 0.5 mg/mL Injection
Eribulin Mesylate 0.5 mg/mL Injection is an intravenous chemotherapy medicine used in the treatment of certain patients with metastatic breast cancer and unresectable or metastatic liposarcoma, as prescribed by qualified oncology specialists.
Cordium Pharmaceuticals Pvt Ltd is a trusted Indian pharmaceutical manufacturer supplying high-quality oncology injectables to hospitals, pharmaceutical distributors, wholesalers, and licensed importers across global markets, subject to local regulatory requirements.
Product Details
Product: Eribulin Mesylate Injection
Strength: 0.5 mg/mL
Dosage Form: Sterile Injection
Route: Intravenous (IV)
Category: Oncology Injectable
Manufacturer: Cordium Pharmaceuticals Pvt Ltd
Export Markets
We support qualified pharmaceutical buyers in:
🇲🇦 Morocco
🇰🇪 Kenya
🇸🇬 Singapore
🇦🇺 Australia
🇩🇪 Germany
🇨🇦 Canada
🇸🇦 Saudi Arabia
Supply is subject to local registration and import regulations.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Competitive export pricing
Quality-focused manufacturing
Reliable global supply
Oncology product expertise
Export documentation support
Timely delivery
Professional customer service
Long-term business partnerships
Frequently Asked Questions
Q. What is Eribulin Mesylate Injection used for?
It is prescribed for certain patients with metastatic breast cancer and unresectable or metastatic liposarcoma according to approved local prescribing information.
Q. Who can buy this product?
Hospitals, oncology centers, licensed pharmaceutical distributors, wholesalers, and authorized importers, subject to local regulations.
Q. Does Cordium Pharmaceuticals export internationally?
Yes. We work with qualified pharmaceutical partners worldwide, subject to applicable export and destination-country requirements.
Q. Can I request bulk pricing?
Yes. Competitive quotations are available based on order quantity, destination, and commercial requirements.
Partner with Cordium Pharmaceuticals Pvt Ltd
If you are looking for a reliable supplier of Eribulin Mesylate 0.5 mg/mL Injection at competitive prices, Cordium Pharmaceuticals Pvt Ltd is your trusted partner for quality oncology medicines and global pharmaceutical exports.
Eribulin Mesylate 0.5 mg/mL Injection is an intravenous chemotherapy medicine used in the treatment of certain patients with metastatic breast cancer and unresectable or metastatic liposarcoma, as prescribed by qualified oncology specialists.
Cordium Pharmaceuticals Pvt Ltd is a trusted Indian pharmaceutical manufacturer supplying high-quality oncology injectables to hospitals, pharmaceutical distributors, wholesalers, and licensed importers across global markets, subject to local regulatory requirements.
Product Details
Product: Eribulin Mesylate Injection
Strength: 0.5 mg/mL
Dosage Form: Sterile Injection
Route: Intravenous (IV)
Category: Oncology Injectable
Manufacturer: Cordium Pharmaceuticals Pvt Ltd
Export Markets
We support qualified pharmaceutical buyers in:
🇲🇦 Morocco
🇰🇪 Kenya
🇸🇬 Singapore
🇦🇺 Australia
🇩🇪 Germany
🇨🇦 Canada
🇸🇦 Saudi Arabia
Supply is subject to local registration and import regulations.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Competitive export pricing
Quality-focused manufacturing
Reliable global supply
Oncology product expertise
Export documentation support
Timely delivery
Professional customer service
Long-term business partnerships
Frequently Asked Questions
Q. What is Eribulin Mesylate Injection used for?
It is prescribed for certain patients with metastatic breast cancer and unresectable or metastatic liposarcoma according to approved local prescribing information.
Q. Who can buy this product?
Hospitals, oncology centers, licensed pharmaceutical distributors, wholesalers, and authorized importers, subject to local regulations.
Q. Does Cordium Pharmaceuticals export internationally?
Yes. We work with qualified pharmaceutical partners worldwide, subject to applicable export and destination-country requirements.
Q. Can I request bulk pricing?
Yes. Competitive quotations are available based on order quantity, destination, and commercial requirements.
Partner with Cordium Pharmaceuticals Pvt Ltd
If you are looking for a reliable supplier of Eribulin Mesylate 0.5 mg/mL Injection at competitive prices, Cordium Pharmaceuticals Pvt Ltd is your trusted partner for quality oncology medicines and global pharmaceutical exports.
Keywords
